Treatment of blood flow abnormality using mucosal delivery of nitric oxide

Drug Delivery and Translational Research

Volumn 1, Issue 3, 2011, Pages 201-208

  Lee, Chi H ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Blood flow abnormality; Mucosal delivery; Nitric oxide delivery; PLGA microparticle

Indexed keywords

DIETHYLENETRIAMINE DIAZENIUMDIOLATE; DRUG CARRIER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; POLYGLACTIN; POLYMER; PRODRUG; UNCLASSIFIED DRUG;

BLOOD FLOW; CONTROLLED DRUG RELEASE; DIABETES MELLITUS; DIABETIC PATIENT; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; EMULSION; FEMALE; FLOW RATE; GENE EXPRESSION; HUMAN; LASER DOPPLER FLOWMETRY; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVIEW; SEXUAL AROUSAL DISORDER; SUSTAINED DRUG RELEASE; TREATMENT OUTCOME; VAGINA MUCOSA;

EID: 84862985302     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-011-0026-2     Document Type: Review

References (52)

1. Suarez J, Davila JC, Real MA, Guirado S, Medina L. Calcium-binding proteins, neuronal nitric oxide synthase, and GABA help to distinguish different pallial areas in the developing and adult chicken. I. Hippocampal formation and hyperpallium. J Comp Neurol. 2006; 497(5): 751-71.
2. Persichini T, Colasanti M, Fraziano M, Colizzi V, Ascenzi P, Lauro GM. Nitric oxide inhibits HIV-1 replication in human astrocytoma cells. Biochem Biophys Res Comm. 1999; 254(1): 200-2.
3. Santilli F, Cipollone F, Mezzetti A, Chiarelli F. The role of nitric oxide in the development of diabetic angiopathy. Horm Metab Res. 2004; 36(5): 319-35.
4. Yamaguchi K, Saito H, Oro S, Tatebe S, Ikeguchi M, Tsujitani S. Expression of inducible nitric oxide synthase is significantly correlated with expression of vascular endothelial growth factor and dendritic cell infiltration in patients with advanced gastric carcinoma. Oncology. 2005; 68(4-6): 471-8.
5. Beigel R, Dvir D, Arbel Y, Shechter A, Feinberg MS, Shechter M. Pulse pressure is a predictor of vascular endothelial function in middle-aged subjects with no apparent heart disease. Vasc Med. 2010; 15: 299-305.
6. Chen K, Keaney J. Reactive oxygen species-mediated signal transduction in the endothelium. Endothelium. 2004; 11(2): 109-21.
7. Hrabie J, Klose J, Wink D, Keefer L. New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem. 1993; 58(6): 1472-6.
8. Changez M, Kang N-G, Lee CH, Lee JS. Reversible and pH sensitive vesicles from amphiphilic homopolymer poly(2-(4-vinylphenyl)pyridine). Small (Small-Journal). 2010; 6(1): 63-8.
9. Chien YW, Lee CH. Drug delivery, vaginal route. In: Encyclopedia of pharmaceutical technology. 2nd ed. Pinehurst: PharmaceuTech; 2002. p. 961-85.
10. Yoo JW, Dharmala K, Lee CH. The physicodynamic properties of mucoadheisve polymeric films developed as female controlled drug delivery system. Int J Pharm. 2006; 309(1-2): 139-49.
11. Yoo JW, Acharya G, Lee CH. In vivo evaluation of vaginal films for mucosal delivery of nitric oxide. Biomaterials. 2009; 30: 3978-85.
12. Farkas K, Sarman B, Jermendy G, Somogyi A. Endothelial nitric oxide in diabetes mellitus: too much or not enough? Diabet Nutr Metab. 2000; 13(5): 287-97.
13. Szeri AJ, Park SC, Verguet S, Weiss A. Katz DF A model of transluminal flow of anti-HIV microbicide vehicle: combined elastic squeezing and gravitational sliding. Phys Fluids. 2008; 20: 083101-10.
14. Bonferoni MC, Giunchedi P, Scalia S, Rossi S, Sandri G, Caramella C. Chitosan gels for the vaginal delivery of lactic acid: relevance of formulation parameters to mucoadhesion and release mechanisms. AAPS PharmSciTech. 2006; 7(5): 104.
15. Lai BE, Xie YQ, Lavine ML, Szeri AJ, Owen DH, Katz DF. Dilution of microbicide gels with vaginal fluid and semen simulants: effect on rheological properties and coating flow. J Pharm Sci. 2008; 97(2): 1030-8.
16. Karim SSA, Baxter C. Antiretroviral prophylaxis for the prevention of HIV infection: future implementation challenges. HIV Therapy. 2009; 3: 3-6.
17. Karim QA, Karim SSA, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of Tenofovir Gel, an Antiretroviral Microbicide, for the prevention of HIV infection in women. Science. 2010; 329(5996): 1168-74.
18. Chang JY, Oh YK, Choi HG, Kim YB, Kim CK. Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological condition. Int J Pharm. 2002; 241: 155-63.
19. Wang Y, Lee CH. In vitro release of sodium dodecyl sulfate from a female controlled drug delivery system. Int J Pharm. 2004; 282(1-2): 173-81.
20. Yoo JW, Giri N, Lee CH. pH-sensitive Eudragit nanoparticles for mucosal drug delivery. Int J Pharmaceutics. 2011; 403: 262-7.
21. Balzarini J, Vahlenkamp T, Egberink H, Hartmann K, Witvrouw M, Pannecouque C, et al. Antiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl) adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9- (2 phosphonyl methoxypropyl) adenine, and MDL 74, 968] in cell cultures and murine sarcoma virus-infected newborn NMRI mice. Antimicrob Agents Chemother. 1997; 41(3): 611-6.
22. Milligan GN, Chu CF, Young CG, Stanberry LR. Effect of candidate vaginally-applied microbicide compounds on recognition of antigen by CD4+ and CD8+ T lymphocytes. Biol Reprod. 2004; 71(5): 1638-45.
23. Kim SW, Bae YH, Okano T. Hydrogels: swelling, drug loading, and release. Pharm Res. 1992; 9: 283-90.
24. Gorodeski GI. The cervical cycle. In: Adashi EY, Rock JA, Rosenwaks Z, editors. Reproductive endocrinology, surgery, and technology. Philadelphia: Lippincott-Raven Publishers; 1996. p. 312-9.
25. Ruel-Gariepy E, Chenite A, Chaput C, Guirguis S, Leroux J. Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int J Pharm. 2000; 203: 89-98.
26. Hunter CA, Nicholas HJ. A study of vaginal acids. Am J Obstet Gynecol. 1959; 78: 282.
27. White DR, Aitken J. Relationship between calcium, cyclic AMP, ATP and intercellular pH and the capacity of hamster spermatozoa to express hyperactivated motility. Gamete Res. 1989; 22: 163.
28. Hernadez RM, Igartua M, Gascon AR, Calvo MB, Pedraz JL. Influence of shaking and surfactants on the release of BSA from plga microspheres. Eur J Drug Metab Pharmacokinet. 1998; 23: 92-6.
29. Sauer SK, Schafer D, Kress M, Reeh PW. Stimulated prostaglandin E2 release from rat skin, in vitro. Life Sci. 1998; 62: 2045-55.
30. Ceschel GC, Maffei P, Borgia SL, Ronchi C, Rossi S. Development of a mucoadhesive dosage form for vaginal administration. Drug Dev Ind Pharm. 2001; 27: 541-7.
31. Lee CH, Moturi V, Lee Y. Thixotropical property in pharmaceutical formulations. J Cont Rel. 2009; 136: 89-98.
32. Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur J Pharmacol. 2005; 511(1): 53-64.
33. Cooke KV. Sexual dysfunction in women. Medial Review. 2004.
34. Ferrini MG, Nolazco G, Vernet D, Gonzalez-Cadavid NF, Berman J. Increased vaginal oxidative stress, apoptosis, and inducible nitric oxide synthase in a diabetic rat model: implications for vaginal fibrosis. Fertil Steril. 2006; 4: 1152-63. 86 Suppl.
35. Park K, Ryu SB, Park YI, Ahn K, Lee SN, Nam JH. Diabetes mellitus induces vaginal tissue fibrosis by TGF-beta 1 expression in the rat model. J Sex Marital Ther. 2001; 27(5): 577-87.
36. Chantler E. Structure and function of cervical mucus. In: Chantler E, Elden J, Elstein M, editors. Mucus in health and diseases. New York: Plenum Press; 1982. vol. II.
37. Giardino I, Edelstein D, Brownlee M. BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest. 1996; 97(6): 1422-8.
38. Yoo JW, Lee JS, Lee CH. Characterization of nitric oxide-releasing microparticles for the mucosal delivery. J Biomed Mater Res. 2010; 92(4): 1233-43.
39. Devine SM, Hoffman R, Verma A, Shah R, Bradlow BA, Stock W, et al. Allogeneic blood stem cell transplantation following reduced intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. Blood. 2002; 99: 2255-8.
40. Fichorova RN, Anderson DJ. Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod. 1999; 60(2): 508-14.
41. Cheeti S, Lee CH. The involvement of intracellular calcium in the regulation of MCT-mediated drug uptake by HeLa cells. Mol Pharm. 2010; 7(1): 169-76.
42. Yoo JW, Choe ES, Ahn SM, Lee CH. Pharmacological activity and protein phosphorylation caused by nitric oxide-releasing microparticles. Biomaterials. 2010; 31: 552-8.
43. Toledano R, Pfaus J. The Sexual Arousal and Desire Inventory (SADI): a multidimensional scale to assess subjective sexual arousal and desire. J Sex Med. 2006; 3(5): 853-77.
44. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol. 2000; 279: L429-38.
45. Newton AC. Protein kinase C: structure, function, and regulation. J Biol Chem. 1995; 270: 28495-8.
46. Chari R, Todd G, Bela Jr N, Kamala B, Yingying M, Yamini SB, et al. Protein kinase Cδ differentially regulates platelet functional responses. Arterioscler Thromb Vasc Biol. 2009; 29: 699-705.
47. Akita Y. Protein kinase C-ε (PKC-ε): its unique structure and function. J Biochem Tokyo. 2002; 132: 847-52.
48. Polgar J, Lane WS, Chung SH, Houng AK, Reed GL. Phosphorylation of SNAP-23 in activated human platelets. J Biol Chem. 2003; 278: 44369-76.
49. Giuliano F, Allard J, Compagnie S, Alexandre L, Droupy S, Bernabe J. Vaginal physiological changes in a model of sexual arousal in anesthetized rats. Am J Physiol Regul Integr Comp Physiol. 2001; 281(1): R140-9.
50. Kim NN, Stankovic M, Armagan A, Cushman TT, Goldstein I, Traish AM. Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat. BMC Womens Health. 2006; 6: 14.
51. Pacher P, Mabley JG, Liaudet L, Evgenov OV, Southan GJ, Abdelkarim GE, et al. Topical administration of a novel nitric oxide donor, linear polyethylenimine-nitric oxide/nucleophile adduct (DS1), selectively increases vaginal blood flow in anesthetized rats. Int J Impot Res. 2003; 15(6): 461-4.
52. Vachon P, Simmerman N, Zahran AR, Carrier S. Increases in clitoral and vaginal blood flow following clitoral and pelvic plexus nerve stimulations in the female rat. Int J Impot Res. 2000; 12(1): 53-7.